← Leaderboards
Paul T Massa
Upstate Medical University
$4,780,712
Attributed
$6,171,645
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $630.2K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,171,645 · 5
By mechanism
R01$6,171,645 · 5
Top collaborators
- Xin Jie Chen5 shared
- Frank A Middleton5 shared
Most similar at Upstate Medical University
Same institution · by research overlap
- Xin Jie Chen$6,569,163
- Sandra M Mooney$7,954,152
- Frank A Middleton$6,954,473
- Liam Patrick Coyne$201,096
- Nicholas Brennan$161,206
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGenesPathway InteractionsProteinsOligodendrogliaNeuraxisOxidative StressPlayDemyelinationsMitochondriaPathologyPtpn6 GeneNeuronsAreaMouse ModelMultiple SclerosisPhenotypeMediatingInterestMolecularIn VivoMacrophageFutureGenetic
Grant awards (21)
Novel mechanism of neural and muscular degeneration$412,099
R01 · FY2024 · AG
Novel mechanism of neural and muscular degeneration$425,051
R01 · FY2023 · AG
Novel mechanism of neural and muscular degeneration$425,051
R01 · FY2022 · AG
Novel mechanism of neural and muscular degeneration$412,099
R01 · FY2021 · AG
Novel mechanism of neural and muscular degeneration$412,099
R01 · FY2020 · AG
Function of SHP-1 in oligodendrocytes$279,125
R01 · FY2015 · NS · contact PI
Function of SHP-1 in oligodendrocytes$276,334
R01 · FY2014 · NS · contact PI
Function of SHP-1 in oligodendrocytes$269,356
R01 · FY2013 · NS · contact PI
Role of SHP-1 in monocyte-mediated demyelination$263,969
R01 · FY2013 · NS · contact PI
Function of SHP-1 in oligodendrocytes$279,125
R01 · FY2012 · NS · contact PI
Role of SHP-1 in monocyte-mediated demyelination$273,543
R01 · FY2012 · NS · contact PI
Role of SHP-1 in monocyte-mediated demyelination$273,543
R01 · FY2011 · NS · contact PI
Deficiency of SHP-1 expression and function in multiple sclerosis$353,250
R01 · FY2010 · NS · contact PI
Role of SHP-1 in monocyte-mediated demyelination$276,937
R01 · FY2010 · NS · contact PI
Deficiency of SHP-1 expression and function in multiple sclerosis$353,250
R01 · FY2009 · NS · contact PI
Regulation of interferon activity by SHP-1 in the CNS$199,971
R01 · FY2007 · NS · contact PI
Regulation of interferon activity by SHP-1 in the CNS$205,943
R01 · FY2006 · NS · contact PI
Regulation of interferon activity by SHP-1 in the CNS$210,900
R01 · FY2005 · NS
REGULATION OF INTERFERON ACTIVITY BY SHP-1 IN THE CNS$190,000
R01 · FY2003 · NS
REGULATION OF INTERFERON ACTIVITY BY SHP-1 IN THE CNS$190,000
R01 · FY2002 · NS
REGULATION OF INTERFERON ACTIVITY BY SHP-1 IN THE CNS$190,000
R01 · FY2001 · NS